Background Proteinuria has been recognized as a marker for an increased risk of chronic renal disease. It is unclear whether arsenic (As) exposure from drinking water is associated with proteinuria.
Introduction
Inorganic arsenic (As) exposure from drinking water has been linked to an elevated risk of internal cancers, [1] [2] [3] [4] [5] [6] diabetes [7] [8] [9] and cardiovascular disease (CVD). [10] [11] [12] [13] [14] Several studies with As exposure measured ecologically have reported a positive association between As exposure, non-malignant chronic kidney diseases, and microvascular diseases such as renal dysfunction. [15] [16] [17] [18] However, the evidence has not been well established because the studies have been limited to using ecological measures of the exposure and/or the disease. In addition, neither a biological mechanism nor the effect of low to moderate levels of exposure is clear.
Proteinuria, or albuminuria, is the presence of an excess of serum proteins in the urine due to damaged glomeruli, the tiny tufts of capillaries that filter blood in the kidney. Proteinuria has long been recognized as a marker for renal disease. Proteinuria is also a well-known predictor of poor renal outcomes in patients with type 2 diabetes and essential hypertension. 19, 20 Risk factors including glucose and cholesterol levels, body mass index (BMI) and blood pressure that are related to renal disease have also been independently associated with incident proteinuria. 21 Studies of As exposure and markers of chronic kidney disease such as proteinuria in populations exposed to a wide range of As levels may extend our knowledge on the biological basis of the relationship between As exposure and renal disease.
It has been estimated that 13 million Americans have been exposed to 10-50 mg/l of As. 22, 23 In Bangladesh, more than 50 million people have been chronically exposed to drinking groundwater with As concentrations exceeding the WHO standard (10 mg/l). 24 In 2000, we established a prospective cohort study of 11 746 individuals in Araihazar, Bangladesh, to assess As-related health effects. The average duration of exposure to well As levels assessed at baseline was 8 years. 25 In addition, at baseline, we implemented an As mitigation program in the study area to promote well switching to safe wells, i.e. wells yielding water with an As concentration less than the Bangladesh standard of 50 mg/l. Within 2 years since baseline, a total of 58% of the 6512 participants with unsafe wells (As 550 mg) at baseline had responded by switching to other wells. 26 The implementation of As mitigation interventions in the cohort provides a unique opportunity to evaluate the health effects related to changes in As exposure over time. With chronic and continuing exposure, steady-state concentrations of As in urine are achieved, and urinary As can serve as a good biomarker for long-term continuing exposure and for tracking changes in exposure due to intervention over time. In the present study, we conducted cross-sectional and cohort analyses to evaluate the associations of As exposure, measured both in water and repeated urinary samples, with the risk of proteinuria detected by urine dipstick.
Methods

Study participants
The Health Effects of Arsenic Longitudinal Study (HEALS) is an ongoing prospective cohort study in Araihazar, Bangladesh. Details of the study methodologies have been presented elsewhere. 27, 28 Briefly, prior to subject recruitment, water samples and geographic positional system (GPS) data were collected for 5966 contiguous wells in a well-defined geographical area of 25 km 2 in Araihazar. Between October 2000 and May 2002, 11 746 men and women were recruited, with a participation rate of 97.5%. 27 Information on demographic and lifestyle variables was collected using a standardized questionnaire at baseline and follow-up visits. Blood pressure was measured by trained clinicians using an automatic sphygmomanometer as previously described. 29 Participants who had a self-reported physician diagnosis of diabetes prior to baseline were retrospectively identified from data collected at the first follow-up, as previously described. 30 The comparison between self-reported diabetes status and test results for blood glycosylated haemoglobin (HbA1c) and glucosuria suggested validity of the questionnaire data. A spot urine sample was collected in 50-ml acid-washed tubes from 95.6, 94.5 and 91.2% of the total cohort participants at baseline, first follow-up and second follow-up visits, respectively. Urine samples were kept in portable coolers immediately after collection. Within 2-8 h, urine samples were processed and transferred to À208C freezers in the study office located in Dhaka city. All samples were kept frozen and shipped to Columbia University on dry ice within 1-2 months.
Proteinuria
At the time of baseline and each of the follow-up visits, dipstick urinalysis was performed by a trained physician on freshly evacuated spot urine samples collected from the participants using the Chemstrip Micral Test Strips (Roche Diagnostics, USA). The study physicians were blinded to urinary As and well As level. 25 The results of the urine test were based on a colour scale that quantified proteinuria as absent, trace, 530,4100 and4500 mg/dl. In the present study, proteinuria was defined as a dipstick finding with trace, 430, 4100 or 4500 mg/dl protein in the urine.
As exposure measurements
Prior to baseline subject recruitment, water samples from all 5966 tube wells in the study area serving the source population were collected in 50-ml acid-washed tubes following well pumping for 5 min. 31, 32 Total As concentration was determined by graphite furnace atomic-absorption spectrometry (GFAA) with a Hitachi Z-8200 system at the Lamont-Doherty Earth observatory of Columbia University. 31 Samples (21%) that fell below the detection limit of GFAA (5 mg/l) were subsequently analysed by inductively coupled plasma mass spectrometry (ICP-MS), which has a detection limit of 0.1 mg/l. 33 All the samples were detectable by ICP-MS. Analyses for time-series samples collected from a sample of 20 tube wells in the study area showed that the As concentration in well water is relatively stable over time. 33 Total urinary As concentration in urine samples collected at baseline and all the follow-up visits were measured by GFAA, using a Perkin-Elmer Analyst 600 graphite furnace system, as previously described. 34 Urinary creatinine was analysed using a method based on the Jaffe reaction for adjustment of urinary total As concentration. 35 In a random 10% of participants, inorganic As (AsV and AsIII) and its metabolites monomethylarsonate (MMA) to dimethylarsinate (DMA) accounted for 96% of total urinary As, whereas arsenobetaine and arsenocholine, derived mainly from dietary intakes of certain marine fish, together accounted for 3%. The correlation of well water As with total urinary As, DMA, and MMA concentrations were 0.70, 0.61 and 0.57, respectively, indicating a good relative validity of total urinary As as a reflection of As exposure from well water.
Statistical analyses
We first conducted descriptive analyses to compare participants with and without proteinuria at baseline, as well as participants who never had proteinuria at any of the follow-up visits, with respect to baseline characteristics. Pair-wise correlations for urinary As at each visit were calculated using urinary creatinineadjusted As.
Unconditional logistic regression was used to evaluate the cross-sectional relationships of baseline well As and urinary As with the prevalence of proteinuria at baseline. We estimated prevalence odds ratios (PORs) for proteinuria in relation to As exposure levels, adjusting for potential confounding variables including age, gender, educational attainment, smoking status, BMI, systolic blood pressure (SBP) and diastolic blood pressure (DBP) and diabetes status. 30 Effect estimates in relation to urinary As were additionally adjusted for urinary creatinine level. Urinary creatinine was adjusted by including it as a separate independent variable in the model, as recommended by Barr et al. 36 and Gamble and Liu, 37 to allow the statistical significance of other variables in the model to be independent of effects of creatinine concentration. There were 11 122 participants with a valid urine dipstick test at baseline (99.1% of those who gave a urine sample), of which 166 subjects were excluded because they were missing on at least one of the covariates of interest ( Figure 1 ).
Proteinuria is a well-known predictor of poor renal outcomes in patients with type 2 diabetes and essential hypertension 19, 20 and As exposure has been associated with both of these conditions. Therefore, in addition to control for diabetes status and both SBP and DBP, analyses were conducted with exclusion of individuals with high blood pressure (SBP 5140 mmHg or DBP 590 mmHg) or individuals with history of diabetes at baseline. Among the first 2100 cohort participants, we measured HbA1c, a long-term marker of plasma glucose concentration. Among these individuals, we estimated PORs for proteinuria in relation to As exposure levels with adjustment for HbA1c and also with exclusion of participants with a high HbA1c level (45.5%).
The prospective cohort analyses included 10 160 participants with a negative urine dipstick test at baseline and non-missing values on the covariates of interest ( Figure 1 ). We considered a positive finding for proteinuria at any of the two follow-up visits as our primary outcome. Cox proportional hazard models, which have been used in other cohort studies with repeated dipstick tests over time, 21 were used to compare the incidence of proteinuria across different levels of baseline well As, baseline urinary As, and change in urinary As since last visit. We estimated hazard ratios (HRs) for the association between arsenic exposure variables and proteinuria adjusting for the above-mentioned potential confounders. Specifically, change in urinary As since the last visit was modelled as a time-dependent variable because the value varied visit by visit. Baseline age, blood Proteinuria status at follow-up was considered censored for those who died, moved, lost to follow-up or did not give urine samples at follow-up. We calculated person-years of observation from the date of baseline visit to the date of follow-up visit with the first positive testing for participants with proteinuria; to death date for those who had died; to the date of move (reported by close relatives or neighbours) for those who moved; and to the date of last follow-up visit for those who tested negative on all the dipstick tests. For the 165 subjects who were lost to follow-up, person-years of observation were considered from baseline to the midpoint between last visit and follow-up visit. We repeated the analyses excluding these subjects and the results did not change appreciably (data not shown). Separate dummy variables for the time-dependent urinary As variables were created for participants who did not give urine samples at first (n ¼ 515) or second follow-up visit (n ¼ 534). Analyses were also conducted for the 9096 participants free of proteinuria at baseline with urinary As values available at all three visits; since results were similar they are not shown. Seafood intakes were not related to urinary As in our population (Hall M, unpublished results). Additional analyses were conducted to control seafood intakes measured by a validated food frequency questionnaire designed for the study population. 38 However, results were similar and therefore are not shown. Sensitivity analyses were also conducted using As measures that incorporated duration of well usages and amount of water consumption such as the time-weighted As concentration and the cumulative As index, as described previously. 25 These measures were highly correlated with well As in the study population; the analysis results using these measures were similar and therefore are not presented. All analyses were conducted using the SAS 9.1.3 statistical package for Windows (SAS Institute Inc., Cary, NC, USA).
Results
The prevalence of proteinuria at baseline was 7.25%, toward the high end of prevalence that has been reported in the literature, ranging from 2.4 to 10% in different populations. 39 The comparison of prevalent cases of proteinuria and non-cases at baseline showed that cases were older, had a higher level of BMI, educational attainment and blood pressure (Table 1) . Compared with participants who did not have proteinuria during the follow-up period, incident cases were older and had a higher level of baseline blood pressure.
In cross-sectional analyses, we found a doseresponse relationship between baseline well As and proteinuria (Table 2) ; the PORs for proteinuria increased with increasing quintiles of baseline well As (P-value for trend <0.01). The ORs for proteinuria comparing the higher four quintiles with the bottom quintile of total urinary As were also elevated. However, there appears to be a threshold effect Over the 4-year follow-up period, among those who were free of proteinuria and who gave a urine sample at all three visits (n ¼ 9224), the correlation of baseline urinary As with urinary As at follow-up visits decreased from 0.66 for the first follow-up to 0.60 for the second follow-up. Baseline well As was strongly correlated with baseline urinary As (r ¼ 0.70, P < 0.01), and moderately correlated with urinary As at the first follow-up (r ¼ 0.49, P < 0.01) and urinary As at the second follow-up (r ¼ 0.45, P < 0.01). Baseline well As was inversely associated with the changes in urinary As (r ¼ À0.18, P < 0.01) between baseline first follow-up visit (r ¼ 0.18, P < 0.01) but was not related to the changes in urinary As between first and second follow-up (r ¼ À0.04, P ¼ 0.18).
There was no apparent association of either baseline well As or baseline urinary As with the incidence of proteinuria (Table 3) . We calculated the difference in total urinary As between visits. Cut points in the analyses were determined using the quintile of changes in urinary As from baseline to the first follow-up visit. There was a positive association between changes in urinary As since last visit and incidence of proteinuria. Participants with an increase of 468 mg/l in urinary As since last visit had a 42% increase in risk of having a positive dipstick testing for proteinuria (HR ¼ 1.42; 95% CI 1.16-1.73), compared with those with a relatively stable urinary As level. Participants with a decrease of 470 mg/l in urinary As since last visit, on the other hand, had a 17% reduction in risk of proteinuria (HR ¼ 0.83; 95% CI 0.67-1.03). We also conducted the same analyses among those consumed water from the baseline well for 45 years. The results were similar and therefore are not shown.
Discussion
To our knowledge, the present study is the first large epidemiological study that has examined the relationship between As exposure from drinking water and proteinuria. We found a positive relationship between baseline As exposure and the prevalence of proteinuria in cross-sectional analyses of baseline data. In prospective cohort analyses, we found positive associations between changes in total urinary As over time and incidence of proteinuria. The concentration of total As in urine has previously been shown to be an excellent biomarker of As exposure in this cohort. 40 The correlation between total urinary As and water As was 40.70 40 and our previous work has shown that urinary As is as strongly predictive as well As of As-induced skin lesions, 27, 41 a hallmark of chronic As poisoning. Therefore, urinary As changes were used as a measure of the changes in As exposure status over time. 26 The cross-sectional analyses showed that the PORs for proteinuria in relation to As exposure did not differ in the subpopulation with water consumption from the baseline well for 55 years (Table 2) , suggesting an effect of long-term exposure to baseline wells. As previously described, an As mitigation program with health education, well labelling and installations of deep wells was initiated in the study area since baseline, which led to changes in urinary As among some cohort participants. 26 The absence of an association between baseline As exposure status and proteinuria incidence during follow-up and the positive association between changes in urinary As and proteinuria incidence together suggest that the effect of recent changes in As exposure overrode the effect of As exposure from the more distant past (44 years ago). The findings indicate that there may be an adverse effect of As exposure on renal function indicated by proteinuria status, and that the effect is modifiable by changes in As exposure status.
Several studies have reported a positive association between As exposure and non-malignant renal disease. [15] [16] [17] 42 . For instance, a standardized mortality ratio (SMR) analysis in a six-county study area of southeastern Michigan, found a positive association between county-level mean As concentrations and kidney disease. 15 SMR analyses in an area in Taiwan with high As exposure showed that mortality from renal disease declined gradually after provision of As-free drinking water. However, the ecological study design and the group level measures of both exposure and the disease limit the interpretation of these results. 16 It is not clear whether the findings were affected by the measurement error of the ecological measure of As exposure or confounding factors not controlled in the study. In addition, previous studies did not exclude the possibility that the observed association is due to the effect of As exposure on blood pressure or type 2 diabetes. In our analyses, the association remained similar with the adjustment for blood pressure status and HbA1c, suggesting that the effect of As on proteinuria is independent of these factors. With the use of proteinuria as a biomarker of renal function, our study provides some evidence of the possible adverse effect of As exposure on renal disease and calls for future research on the topic. HRs were adjusted for age, gender, BMI, cigarette smoking status, education length, SBP, DBP, diabetes status and urinary creatinine measured at each visit in the model. HRs associated with baseline well and urinary As were adjusted for change in urinary As since last visit. HRs associated with change in urinary As since last visit were adjusted for baseline well As.
ARSENIC EXPOSURE AND PROTEINURIA Strengths of the study include the availability of multiple As exposure measures at the individual level, the use of both cross-sectional and prospective cohort analyses, and the large variation in exposure levels in the study population. The study also has several limitations. Using a simple urine dipstick screening method may lead to misclassification of proteinuria. Conditions such as alkaline urine, gross blood in the urine, accidental introduction of detergents to the urine collection and fever may lead to some false positive results. 15 It is unlikely that these states are related to As exposure and therefore the misclassification should be non-differential. By regarding trace proteinuria as positives, the sensitivity of the urine protein dipstick test for micro-and macro-albuminuria can be improved, while its specificity is not changed. 43 The use of multiple dipstick tests over time should also improve the overall sensitivity.
In conclusion, we found positive associations between long-term As exposure and the prevalence of proteinuria and between changes in urinary As since baseline and incidence of proteinuria. Proteinuria may be an early and easily detectable sign for renal impairment induced by As exposure. Future studies are needed to investigate the relationship between As exposure and renal dysfunction and its biomarkers such as b-2 microglobulin.
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KEY MESSAGES
The relationship between As exposure from drinking water and the risk of proteinuria has not been well characterized.
In a Bangladeshi population with low to moderate levels of As exposure, a dose-response relationship between baseline well As concentration and the prevalence of proteinuria was observed.
During follow-up, increasing levels of urinary As were associated with an increased risk of proteinuria, and decreasing levels of urinary As were related to a reduced risk of proteinuria.
